Alasdair P. MacGowan, MD (he/him/his)

Consultant in Infection Researvh
North Bristol NHS Trust, United Kingdom

Disclosure(s): GSK: Grant/Research Support; InfectoPharm: Grant/Research Support; Merck: Advisor/Consultant; Shionogi: Advisor/Consultant; Venatorx: Advisor/Consultant

Alasdair MacGowan BMedBiol, MD, FRCP, FRCPath, FESCMID is Consultant in Infection Research and Professor of Antimicrobial Therapeutics at North Brsitol NHS Trust and the University of Bristol, Bristol, UK

His research interests are in antibacterial pharmacokinetics and pharmacodynamics and he holds a number of public and private sector grants in the area of pre clincial PK-PD assessment of new and older anti infective agents. He has over 350 medline citations and a Web of Science h score of 47

Poster(s):

• 617 - Pharmacodynamics of Ceftolozane-Tazobactam (C/T) as Monotherapy and in Combination with Tobramycin or Fosfomycin Against P.aeruginosa with C/T MICs at or Above 4mg/L
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET